Breaking News, Financial News

2Q Financial Report: PPD

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PPD 2Q Revenue: $309 million (+26%) 2Q Earnings: $36.4 million (+75%) YTD Revenue: $608 million (+24%) YTD Earnings: $78 million (+46%) Comments: Development segment revenue for the quarter was $278.9 million, up 24%. Discovery sciences segment revenue was $4.6 million, up 27%. R&D expense for the quarter was $1.3 million compared to $11.4 million in 2Q2005. This decline was related to the July 2005 transfer of PPD’s development and commercialization rights to the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters